BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maltezou HC, Asimakopoulos G, Stavrou S, Daskalakis G, Koutroumanis P, Sindos M, Theodora M, Katerelos P, Kostis E, Gavrili S, Kossyvakis A, Theodoridou M, Mentis A, Drakakis P, Loutradis D, Rodolakis A. Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019. Vaccine 2020;38:4625-31. [PMID: 32402751 DOI: 10.1016/j.vaccine.2020.04.060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Zhong J, Zhang D. Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review. Vaccines 2022;10:1083. [DOI: 10.3390/vaccines10071083] [Reference Citation Analysis]
2 Maltezou HC, Stavros S, Asimakopoulos G, Pergialiotis V, Raftopoulos V, Talias MA, Pavli A, Daskalakis G, Sindos M, Koutroumanis P, Theodora M, Antsaklis P, Kostis E, Stratiki E, Kossyvakis A, Theodoridou M, Mentis A, Drakakis P, Loutradis D, Rodolakis A. Effectiveness of maternal vaccination with quadrivalent inactivated influenza vaccine in pregnant women and their infants in 2019-2020. Expert Rev Vaccines 2021. [PMID: 34878959 DOI: 10.1080/14760584.2022.2013820] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Maltezou HC, Effraimidou E, Cassimos DC, Medic S, Topalidou M, Konstantinidis T, Theodoridou M, Rodolakis A. Vaccination programs for pregnant women in Europe, 2021. Vaccine 2021;39:6137-43. [PMID: 34462162 DOI: 10.1016/j.vaccine.2021.08.074] [Reference Citation Analysis]
4 Boccalini S, Pariani E, Calabrò GE, DE Waure C, Panatto D, Amicizia D, Lai PL, Rizzo C, Amodio E, Vitale F, Casuccio A, DI Pietro ML, Galli C, Bubba L, Pellegrinelli L, Villani L, D'Ambrosio F, Caminiti M, Lorenzini E, Fioretti P, Micale RT, Frumento D, Cantova E, Parente F, Trento G, Sottile S, Pugliese A, Biamonte MA, Giorgetti D, Menicacci M, D'Anna A, Ammoscato C, LA Gatta E, Bechini A, Bonanni P. [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®]. J Prev Med Hyg 2021;62:E1-E118. [PMID: 34909481 DOI: 10.15167/2421-4248/jpmh2021.62.2s1] [Reference Citation Analysis]
5 Sam IC, Ahmad Jaafar N, Wong LP, Nathan AM, de Bruyne JA, Chan YF. Socioeconomic costs of children <5 years hospitalised with acute respiratory infections in Kuala Lumpur, Malaysia. Vaccine 2021;39:2983-8. [PMID: 33931252 DOI: 10.1016/j.vaccine.2021.04.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Maltezou HC, Rodolakis A. Vaccination of pregnant women against influenza: what is the optimal timing? Hum Vaccin Immunother 2021;:1-5. [PMID: 33599569 DOI: 10.1080/21645515.2021.1889934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]